Assembly Biosciences (ASMB) Shares Outstanding (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Shares Outstanding (Entity) of $15.9 million for Q1 2026, up 108.59% year-over-year from $7.6 million in Q1 2025, and up 41.76% quarter-over-quarter from $11.2 million in Q4 2025.
Assembly Biosciences (ASMB) Shares Outstanding (2010 - 2026) Analysis & Trends
Assembly Biosciences' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $15.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 108.59% year-over-year to $15.9 million; the TTM figure through Mar 2026 stood at $15.9 million (up 108.59% YoY), while the FY2025 annual figure was $11.2 million, up 86.71% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $15.9 million, up from $11.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $15.9 million in Q1 2026, with the low at $4.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $5.5 million (2023), against an average of $6.7 million.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) rose 1.61% in 2022, then surged 108.59% in 2026.
- Assembly Biosciences' Shares Outstanding (Entity) stood at $4.1 million in 2022, then surged by 34.57% to $5.5 million in 2023, then climbed by 9.52% to $6.0 million in 2024, then surged by 86.71% to $11.2 million in 2025, then surged by 41.76% to $15.9 million in 2026.
- Business Quant data shows ASMB's Shares Outstanding (Entity) at $15.9 million in Q1 2026, $11.2 million in Q4 2025, and $12.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 18.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.85 Mn |
| Mar 31, 2026 | 16.90 Mn |
| Dec 31, 2025 | 11.21 Mn |
| Sep 30, 2025 | 12.69 Mn |
| Jun 30, 2025 | 7.66 Mn |
| Mar 31, 2025 | 7.51 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.48 Mn |
| Dec 31, 2023 | 4.58 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 4.35 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 4.03 Mn |
| Sep 30, 2022 | 4.04 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 3.61 Mn |
| Sep 30, 2021 | 3.80 Mn |